Robert Stratta to Treatment Outcome
This is a "connection" page, showing publications Robert Stratta has written about Treatment Outcome.
Connection Strength
0.730
-
Sanders BP, Orlando G, Peloso A, Katari RS, Iskandar SS, Farney AC, Rogers J, Soker S, Stratta RJ. Osseus metaplasia in kidney allografts as a paradigm of regenerative medicine principles. Exp Clin Transplant. 2014 Aug; 12(4):371-3.
Score: 0.073
-
Singh RP, Farney AC, Rogers J, Gautreaux M, Reeves-Daniel A, Hartmann E, Doares W, Iskandar S, Adams P, Stratta RJ. Hypertension in standard criteria deceased donors is associated with inferior outcomes following kidney transplantation. Clin Transplant. 2011 Jul-Aug; 25(4):E437-46.
Score: 0.058
-
Singh RP, Farney AC, Rogers J, Zuckerman J, Reeves-Daniel A, Hartmann E, Iskandar S, Adams P, Stratta RJ. Kidney transplantation from donation after cardiac death donors: lack of impact of delayed graft function on post-transplant outcomes. Clin Transplant. 2011 Mar-Apr; 25(2):255-64.
Score: 0.057
-
Stratta RJ, Farney AC, Rogers J. Import pancreas allografts: good from far or far from good? Transplantation. 2009 Sep 15; 88(5):622-3.
Score: 0.052
-
Moore PS, Farney AC, Sundberg AK, Rohr MS, Hartmann EL, Iskandar SS, Gautreaux MD, Rogers J, Doares W, Anderson TK, Adams PL, Stratta RJ. Dual kidney transplantation: a case-control comparison with single kidney transplantation from standard and expanded criteria donors. Transplantation. 2007 Jun 27; 83(12):1551-6.
Score: 0.044
-
Rogers J, Stratta RJ. The metabolic syndrome as a risk factor in simultaneous kidney-pancreas transplantation. Nat Clin Pract Endocrinol Metab. 2007 Jul; 3(7):498-9.
Score: 0.044
-
Moore PS, Farney AC, Sundberg AK, Rohr MS, Hartmann EL, Iskandar SS, Gautreaux MD, Rogers J, Doares W, Anderson TK, Adams PL, Stratta RJ. Experience with dual kidney transplants from donors at the extremes of age. Surgery. 2006 Oct; 140(4):597-605; discussion 605-6.
Score: 0.042
-
Stratta RJ, Rohr MS, Sundberg AK, Farney AC, Hartmann EL, Moore PS, Rogers J, Iskandar SS, Gautreaux MD, Kiger DF, Doares W, Anderson TK, Hairston G, Adams PL. Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality? Ann Surg. 2006 May; 243(5):594-601; discussion 601-3.
Score: 0.041
-
Stratta RJ, Sundberg AK, Rohr MS, Farney AC, Hartmann EL, Roskopf JA, Iskandar SS, Hairston G, Kiger DF, Gautreaux MD, Anderson TK, Adams PL. Optimal use of older donors and recipients in kidney transplantation. Surgery. 2006 Mar; 139(3):324-33.
Score: 0.040
-
Stratta RJ, Rohr MS, Sundberg AK, Armstrong G, Hairston G, Hartmann E, Farney AC, Roskopf J, Iskandar SS, Adams PL. Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. Ann Surg. 2004 May; 239(5):688-95; discussion 695-7.
Score: 0.036
-
Stratta RJ, Lo A, Shokouh-Amiri MH, Egidi MF, Gaber LW, Gaber AO. Improving results in solitary pancreas transplantation with portal-enteric drainage, thymoglobin induction, and tacrolimus/mycophenolate mofetil-based immunosuppression. Transpl Int. 2003 Mar; 16(3):154-60.
Score: 0.033
-
Stratta RJ, Shokouh-Amiri MH, Egidi MF, Grewal HP, Lo A, Kizilisik AT, Nezakatgoo N, Gaber LW, Gaber AO. Long-term experience with simultaneous kidney-pancreas transplantation with portal-enteric drainage and tacrolimus/mycophenolate mofetil-based immunosuppression. Clin Transplant. 2003; 17 Suppl 9:69-77.
Score: 0.033
-
Stratta RJ, Alloway RR, Hodge E, Lo A. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis. Clin Transplant. 2002 Feb; 16(1):60-8.
Score: 0.031
-
Alfrey EJ, Lu AD, Carter JT, Bowers V, Taylor R, Ratner L, Cole E, Schweitzer E, Krishnamurthi V, Tan H, Stratta R. The dual kidney transplant registry. Transplant Proc. 2001 Feb-Mar; 33(1-2):1099-100.
Score: 0.028
-
Sudan D, Sudan R, Stratta R. Long-term outcome of simultaneous kidney-pancreas transplantation: analysis of 61 patients with more than 5 years follow-up. Transplantation. 2000 Feb 27; 69(4):550-5.
Score: 0.027
-
Chen A, Farney A, Russell GB, Nicolotti L, Stratta R, Rogers J, Lin JJ. Severe intellectual disability is not a contraindication to kidney transplantation in children. Pediatr Transplant. 2017 May; 21(3).
Score: 0.022
-
Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND, Palanisamy A, Reeves-Daniel AM, Brown WM, Divers J. APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. Transplantation. 2016 Jan; 100(1):194-202.
Score: 0.020
-
Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW, Langefeld CD, Hicks PJ, Ma L, Freedman BI. Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Kidney Int. 2015 Sep; 88(3):584-92.
Score: 0.019
-
Fadeyi EA, Stratta RJ, Farney AC, Pomper GJ. Successful unintentional ABO-incompatible renal transplantation: Blood group A1B donor into an A2B recipient. Am J Clin Pathol. 2014 May; 141(5):724-6.
Score: 0.018
-
Gaber LW, Egidi MF, Stratta RJ, Lo A, Moore LW, Gaber AO. Clinical utility of histological features of polyomavirus allograft nephropathy. Transplantation. 2006 Jul 27; 82(2):196-204.
Score: 0.010
-
Shaw BW, Markin R, Stratta R, Langnas A, Donovan J, Sorrell M. FK 506 for rescue treatment of acute and chronic rejection in liver allograft recipients. Transplant Proc. 1991 Dec; 23(6):2994-5.
Score: 0.004